Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...

Add Yahoo as a preferred source to see more of our stories on Google. Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Designed to reduce daily insulin injections to a single weekly dose, the long-acting insulin aims to improve treatment ...

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to research from the ...

A team of chemists, polymer scientists and drug delivery specialists at Zhejiang University, working with a pair of colleagues from the University of North Carolina at Chapel Hill, has developed a ...